Patents by Inventor John L. Johnson

John L. Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250049464
    Abstract: An ultrasonic instrument includes a body, an actuation assembly, a shaft assembly, and an end effector. The actuation assembly includes an activation member that is operable to move in a first direction to select a mode of operation. The shaft assembly extends distally from the body and includes an acoustic waveguide. The end effector includes an ultrasonic blade that is in acoustic communication with the acoustic waveguide. The activation member is operable to move in a second direction to activate the end effector in a mode of operation selected by movement of the activation member in the first direction.
    Type: Application
    Filed: October 30, 2024
    Publication date: February 13, 2025
    Inventors: John A. Hibner, Kevin L. Houser, David A. Monroe, David C. Cagle, Geoffrey S. Strobl, Timothy P. Lessek, Jeffrey L. Aldridge, Ryan M. Asher, Mary E. Mootoo, Eric B. Smith, Gregory W. Johnson, David M. Locke
  • Publication number: 20250049355
    Abstract: Certain aspects of the present disclosure provide a monitoring system comprising a continuous analyte sensor configured to penetrate a skin of a patient and generate a sensor current indicative of analyte levels of the patient, and a sensor electronics module coupled to the continuous analyte sensor. The sensor electronics module comprises an analog to digital converter configured to receive the sensor and convert the sensor current generated by the continuous analyte sensor into digital signals, one or more processors configured to convert the digital signals to a set of analyte measurements indicative of the analyte levels of the patient, and a Bluetooth antenna configured to transmit the set of analyte measurements wirelessly to a wireless communications device using Bluetooth or BLE communications protocols.
    Type: Application
    Filed: August 1, 2024
    Publication date: February 13, 2025
    Inventors: Qi AN, Matthew L. JOHNSON, John PADERI, Rush BARTLETT
  • Publication number: 20250026952
    Abstract: Coating compositions may combine durability and stain resistance with reduced environmental emissions and health risks. A coating composition may comprise an isocyanate component, an amine-functional resin comprising an aspartic amine, a reactive silicone component having a molecular weight of at least of 500, and TiO2 in an amount of at least 5 wt. %. The coating composition may further comprise a cure retardant in an amount of at least 5 wt. % and a solvent in an amount of up to 20 wt. %.
    Type: Application
    Filed: June 7, 2023
    Publication date: January 23, 2025
    Applicant: PPG Industries Ohio, Inc.
    Inventors: Chinming Hui, Edward R. Millero, JR., John M. Bennett, Patricia Olivia Trevino Suarez del Real, David J. Schmidt, Chandler L. Johnson, Wells B. Warren, III, Gobinda Saha, William Earl Ishmael, JR., Matthew Pell
  • Patent number: 12203828
    Abstract: The present disclosure relates to systems and methods for detecting anomalies in a semiconductor processing system. According to certain embodiments, one or more external sensors are mounted to a sub-fab component, communicating with the processing system via a communication channel different than a communication channel utilized by the sub-fab component and providing extrinsic sensor data that the sub-fab component is not configured to provide. The extrinsic sensor data may be combined with sensor data from a processing tool of the system and/or intrinsic sensor data of the sub-fab component to form virtual sensor data. In the event the virtual data exceeds or falls below a threshold, an intervention or a maintenance signal is dispatched, and in certain embodiments, an intervention or maintenance action is taken by the system.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: January 21, 2025
    Assignee: Applied Materials, Inc.
    Inventors: Ryan T. Downey, Hemant P. Mungekar, James L'Heureux, Andreas Neuber, Michael W. Johnson, Joseph A. Van Gompel, Gino Gerardo Crispieri, Tony H. Tong, Maxime Cayer, John L Koenig, Mike M. Huang
  • Publication number: 20130105231
    Abstract: An earth boring cutting insert including a cemented carbide comprising metal carbide grains dispersed in a metallic binder including at least one of platinum, palladium, rhenium, rhodium, and ruthenium.
    Type: Application
    Filed: November 1, 2011
    Publication date: May 2, 2013
    Applicant: TDY Industries, Inc.
    Inventors: James J. Oakes, Prakash K. Mirchandani, Gabriel B. Collins, Oladapo O. Eso, John L. Johnson
  • Publication number: 20090221492
    Abstract: Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention. Transgenic animals of the present invention are produced by introducing into developing embryos DNA that encodes Factor IX, such that the foreign DNA is stably incorporated in the DNA of germ line cells of the mature animal. Particularly efficient expression was accomplished using a chimeric construct comprising a mammary gland specific promoter, Factor IX cDNA that lacked the complete or any portion of the 5?-untranslated and 3?-untranslated region, which is substituted with a 5-? and 3?-end of the mouse whey acidic protein gene. In vitro cell cultures of cells explanted from the transgenic mammal of the invention and methods of producing Factor IX from such said culture and methods of treating hemophilia B are also described.
    Type: Application
    Filed: August 29, 2008
    Publication date: September 3, 2009
    Inventors: William H. Velander, William N. Drohan, Henryk Lubon, John L. Johnson, Mary Ann H. Johnson
  • Patent number: 7552074
    Abstract: A network for managing account addresses (such as for credit card accounts) where correspondence and other communications mailed to account holders may have different purposes (e.g., credit card statement, new credit card, marketing correspondence). The network has a database for storing addresses and a database management system for retrieving those addresses. A default address is provided when there is no address stored in the database for the intended purpose of a mailing. The addresses are in categories, with each category associated with a different communication purpose, and with multiple addresses in each category. The multiple addresses within each category may be permanent, temporary or repeating. If temporary or repeating, effective start and end dates are associated with the addresses. There may be multiple cardholders for each account, in which case the address categories (and multiple addresses within each category) are associated with each cardholder.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: June 23, 2009
    Assignee: First Data Corporation
    Inventors: Heather Bruce, Doug Stewart, Margaret A. Henry, Jacquelyn S. Rongish, Gretchen L. Donlin, Matthew A. Rademacher, John L. Johnson, Jeffrey A. Harpenau, Michael B. Grear
  • Patent number: 7435869
    Abstract: A transgenic, non-human mammalian animal is capable of expressing a heterologous gene for human or other recombinant physiologically functional fibrinogen holoprotein or individual subunit chain polypeptides thereof or a modified or fusion fibrinogen in mammary glands of the animals and secreting the expressed product into a body fluid. Methodology employing such a mammal yields recombinant physiologically functional fibrinogens, subunit chain polypeptides thereof, and modified or fusion fibrinogens.
    Type: Grant
    Filed: January 24, 2005
    Date of Patent: October 14, 2008
    Assignees: Virgina Tech. Intellectual Properties, Inc., American National Red Cross, University of North Carolina at Chapel Hill
    Inventors: William H. Velander, William N. Drohan, Henryk Lubon, John L. Johnson
  • Patent number: 7419948
    Abstract: Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention. Transgenic animals of the present invention are produced by introducing into developing embryos DNA that encodes Factor IX, such that the foreign DNA is stably incorporated in the DNA of germ line cells of the mature animal. Particularly efficient expression was accomplished using a chimeric construct comprising a mammary gland specific promoter, Factor IX cDNA that lacked the complete or any portion of the 5?-untranslated and 3?-untranslated region, which is substituted with a 5-? and 3?-end of the mouse whey acidic protein gene. In vitro cell cultures of cells explanted from the transgenic mammal of the invention and methods of producing Factor IX from such said culture and methods of treating hemophilia B are also described.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: September 2, 2008
    Assignees: American Red Cross, Virginia Tech Intellectual Properties, Inc.
    Inventors: William H. Velander, William N. Drohan, Henryk Lubon, Mary Ann H. Johnson, legal representative, John L. Johnson
  • Patent number: 7099878
    Abstract: A network for managing account addresses (such as for credit card accounts) where correspondence and other communications mailed to account holders may have different purposes (e.g., credit card statement, new credit card, marketing correspondence). The network has a database for storing addresses and a database management system for retrieving those addresses. A default address is provided when there is no address stored in the database for the intended purpose of a mailing. The addresses are in categories, with each category associated with a different communication purpose, and with multiple addresses in each category. The multiple addresses within each category may be permanent, temporary or repeating. If temporary or repeating, effective start and end dates are associated with the addresses. There may be multiple cardholders for each account, in which case the address categories (and multiple addresses within each category) are associated with each cardholder.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: August 29, 2006
    Assignee: First Data Corporation
    Inventors: Heather Bruce, Doug Stewart, Margaret A. Henry, Jacquelyn S. Rongish, Gretchen L. Donlin, Matthew A. Rademacher, John L. Johnson, Jeffrey A. Harpenau, Michael B. Grear
  • Patent number: 6984772
    Abstract: A transgenic, non-human mammalian animal is capable of expressing a heterologous gene for human or other recombinant physiologically functional fibrinogen holoprotein or individual subunit chain polypeptides thereof or a modified or fusion fibrinogen in mammary glands of the animals and secreting the expressed product into a body fluid. Methodology employing such a mammal yields recombinant physiologically functional fibrinogens, subunit chain polypeptides thereof, and modified or fusion fibrinogens.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: January 10, 2006
    Assignees: Virginia Tech Intellectual Properties, Inc., American Red Cross, The University of North Carolina at Chapel Hill
    Inventors: William H. Velander, William N. Drohan, Henryk Lubon, John L. Johnson
  • Patent number: 6970900
    Abstract: An optical system utilizing phosphors to perform mathematical operations without the direct or necessary use of an electronic component or electrical power source is disclosed. The luminenscent and quenching properties of phosphors are combined with at least one first-order relaxation subsystem such that when the optical system achieves equilibrium, it will have performed certain mathematical operations. The precise mathematical operation to be performed is determined by controlling the materials utilized, light inputs, and certain variables within the optical system.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: November 29, 2005
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: John L. Johnson
  • Patent number: 6774996
    Abstract: A method and an apparatus for measuring the density variations, static and dynamic, in substances that are at least partially transparent to electromagnetic waves is disclosed. A special birefringement crystal phase shifting assembly encodes the angle of incidence resulting from the refractive effects of the electromagnetic waves having passed through a density variation. The angle of incidence is encoded as a poralization phase shift. Specifically, the poralization phase shift is between the ordinary and the extraordinary rays. That poralization phase shift has a known and definable relationship to the gas density experienced by the electromagnetic wave during its path.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: August 10, 2004
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: John L. Johnson
  • Publication number: 20030227621
    Abstract: A method and an apparatus for measuring the density variations, static and dynamic, in substances that are at least partially transparent to electromagnetic waves is disclosed. A special birefringement crystal phase shifting assembly encodes the angle of incidence resulting from the refractive effects of the electromagnetic waves having passed through a density variation. The angle of incidence is encoded as a poralization phase shift. Specifically, the poralization phase shift is between the ordinary and the extraordinary rays. That poralization phase shift has a known and definable relationship to the gas density experienced by the electromagnetic wave during its path.
    Type: Application
    Filed: June 11, 2002
    Publication date: December 11, 2003
    Inventor: John L. Johnson
  • Publication number: 20030191778
    Abstract: A network for managing account addresses (such as for credit card accounts) where correspondence and other communications mailed to account holders may have different purposes (e.g., credit card statement, new credit card, marketing correspondence). The network has a database for storing addresses and a database management system for retrieving those addresses. A default address is provided when there is no address stored in the database for the intended purpose of a mailing. The addresses are in categories, with each category associated with a different communication purpose, and with multiple addresses in each category. The multiple addresses within each category may be permanent, temporary or repeating. If temporary or repeating, effective start and end dates are associated with the addresses. There may be multiple cardholders for each account, in which case the address categories (and multiple addresses within each category) are associated with each cardholder.
    Type: Application
    Filed: April 8, 2002
    Publication date: October 9, 2003
    Applicant: First Data Corporation
    Inventors: Heather Bruce, Doug Stewart, Margaret A. Henry, Jacquelyn S. Rongish, Gretchen L. Donlin, Matthew A. Rademacher, John L. Johnson, Jeffrey A. Harpenau
  • Publication number: 20030137707
    Abstract: An optical system utilizing phosphors to perform mathematical operations without the direct or necessary use of an electronic component or electrical power source is disclosed. The luminenscent and quenching properties of phosphors are combined with at least one first-order relaxation subsystem such that when the optical system achieves equilibrium, it will have performed certain mathematical operations. The precise mathematical operation to be performed is determined by controlling the materials utilized, light inputs, and certain variables within the optical system.
    Type: Application
    Filed: January 22, 2002
    Publication date: July 24, 2003
    Inventor: John L. Johnson
  • Publication number: 20020166130
    Abstract: Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention. Transgenic animals of the present invention are produced by introducing into developing embryos DNA that encodes Factor IX, such that the foreign DNA is stably incorporated in the DNA of germ line cells of the mature animal. Particularly efficient expression was accomplished using a chimeric construct comprising a mammary gland specific promoter, Factor IX cDNA that lacked the complete or any portion of the 5′-untranslated and 3′-untranslated region, which is substituted with a 5-′ and 3′- end of the mouse whey acidic protein gene. In vitro cell cultures of cells explanted from the transgenic mammal of the invention and methods of producing Factor IX from such said culture and methods of treating hemophilia B are also described.
    Type: Application
    Filed: February 5, 2002
    Publication date: November 7, 2002
    Applicant: AMERICAN CROSS & VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
    Inventors: William H. Velander, William N. Drohan, Henryk Lubon, John L. Johnson, Mary Ann H. Johnson
  • Patent number: 6348998
    Abstract: Polarization phase plate Assembly comprises at least two uniaxial crystal plates which are identical to each other in structure and dimension and a retarder plate sandwiched between the two uniaxial crystal plates. Initially the optic axes of the crystal plates are aligned to be parallel with each other. Then the plates are subsequently rotated around the normals of the plates by an equal twist angle but in opposite directions. When a beam of light is passed through the assembly post-twist, the result is high-quality fringes that are straight, smooth and capable of exhibiting close to 100% contrast. The fringes have a sinusoidal cross-fringe profile and vary in number in relation to the degree of the twist angle.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: February 19, 2002
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: John L. Johnson
  • Patent number: 6344596
    Abstract: Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention. Transgenic animals of the present invention are produced by introducing into developing embryos DNA that encodes Factor IX, such that the foreign DNA is stably incorporated in the DNA of germ line cells of the mature animal. Particularly efficient expression was accomplished using a chimeric construct comprising a mammary gland specific promoter, Factor IX cDNA that lacked the complete or any portion of the 5′-untranslated and 3′-untranslated region, which is substituted with a 5′- and 3′-end of the mouse whey acidic protein gene. In vitro cell cultures of cells explanted from the transgenic mammal of the invention and methods of producing Factor IX from such said culture and methods of treating hemophilia B are also described.
    Type: Grant
    Filed: September 15, 1999
    Date of Patent: February 5, 2002
    Assignees: American Red Cross, Virginia Tech Intellectual Properties, Inc.
    Inventors: William H. Velander, William N. Drohan, Henryk Lubon, John L. Johnson
  • Patent number: 6275327
    Abstract: The all-optical pulse generating and amplifying system utilizes a phosphor that is excited by input light of a first wavelength and, in response, emits light of a second wavelength. The light emitted by the phosphor illuminates a bistable element which, at a pre-fixed intensity of the phosphor-emitted light, switches from non-transmissive state to transmissive state, thereby allowing the exit of light (also of first wavelength) emitted by an output light source as light pulse output of the system. An inhibitory light that also passes through the bistable element during its transmissive state quenches the phosphor light emission and returns the bistable element to its non-transmissive state and re-starts the process toward the next transmissive state. By gating the intensity, via selected non-linearity of the bistable element, of the light output in proportion to the intensity of the input light, the system can also function as an amplifier.
    Type: Grant
    Filed: March 22, 1999
    Date of Patent: August 14, 2001
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: John L. Johnson, William A. Friday, Gary L. Wood